The combination of memantine and galantamine improves cognition in rats: The synergistic role of the α7 nicotinic acetylcholine and NMDA receptors
The combination of memantine and galantamine improves cognition in rats: The synergistic role of the α7 nicotinic acetylcholine and NMDA receptors
复制标题
DOI:
10.1016/j.bbr.2016.07.023
复制
发表时间:
2016-10-15
影响因子:
2.7
通讯作者:
Popik, Piotr
中科院分区:
文献类型:
--
作者:
Nikiforuk, Agnieszka;Potasiewicz, Agnieszka;Popik, Piotr
The combination of memantine and acetylcholinesterase inhibitors (AChEIs) is used as a therapeutic strategy to improve cognition in Alzheimer's disease. Among AChEIs, galantamine, which is also a positive allosteric modulator (PAM) of nicotinic acetylcholine receptors (nAChRs), including alpha 7-nAChRs, may be particularly beneficial. The alpha 7-nAChR is involved in interactions between the cholinergic and glutamatergic systems. In the present study, we investigated the potential role of alpha 7-nAChRs in the pro cognitive effects of this drug combination. To this aim, cognitive performance in rats was assessed using the attentional set shifting task (ASST) and novel object recognition task (NORT).Co-administration of inactive doses of memantine with galantamine facilitated the rats' set-shifting performance and reversed delay-induced deficits in object recognition. These effects were blocked by the alpha 7-nAChR antagonist methyllycaconitine, suggesting that the observed cognitive enhancement is alpha 7-nAChR dependent. Moreover, combined administration of memantine with inactive doses of selective alpha 7-nAChRs PAMs, CCMI and PNU-120596, also improved ASST and NORT performance in a methyllycaconitine-dependent manner.Stimulation of alpha 7-nAChRs may underlie the pro-cognitive effects of combining memantine and galantamine. Our results suggest that memantine, when given with enhancers of alpha 7-nAChRs, may represent an effective strategy for cognitive improvement. (C) 2016 Elsevier B.V. All rights reserved.